The neurodegenerative process in a neurotoxic rat model and in patients with Huntington's disease: Histopathological parallels and differences

Acta Histochemica

Volumn 113, Issue 8, 2011, Pages 783-792

  Gunčová, Ivana ^a   Látr, Ivan ^b   Mazurová, Yvona ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Histopathology; Huntington's disease; Immunohistochemistry; Neuronal degeneration; Neuropil; Neurotoxic rat model; Reactive astrogliosis

Indexed keywords

ADULT; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN ATROPHY; CELL DENSITY; CELL INTERACTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE SEVERITY; FEMALE; GLIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NEUROPIL; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; RAT; STRIATE CORTEX; STRUCTURE ANALYSIS; SURVIVAL TIME;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLIOSIS; HUMANS; HUNTINGTON DISEASE; MALE; NERVE DEGENERATION; OLIGODENDROGLIA; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 80855164569     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2010.11.007     Document Type: Article

References (38)

1. Bates G.P., Mangiarini L., Mahal A., Davies S.W. Transgenic models of the Huntington's disease. Hum Mol Genet 1997, 6:1633-1637.
2. Bates G.P., Gonitel R. Mouse models of triplet repeat diseases. Mol Biotechnol 2006, 32:147-158.
3. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 1986, 321:168-171.
4. Björklund H., Olson L., Dahl D., Schwarcz R. Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes. Brain Res 1986, 371:267-277.
5. Bruyn G.W., Bots G.Th.A.M., Dom R. Huntington's chorea: current neuropathological status. Huntington's disease. Advances in Neurology 1979, vol. 23:83-91. Raven Press, New York.
6. Buffo A., Rite I., Tripathi P., Lepier A., Colak D., Horn A.P., et al. Origin and progeny of reactive gliosis: a source of multipotent cells in the injured brain. Proc Natl Acad Sci USA 2008, 105:3581-3586.
7. Chen Y., Swanson R.A. Astrocytes and brain injury. J Cereb Blood Flow Metab 2003, 23:137-149.
8. Cotrina M.L., Nedergaard M. Astrocytes in the aging brain. J Neurosci Res 2002, 67:1-10.
9. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000, 25:1439-1451.
10. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res Bull 1999, 49:377-391.
11. Ferrante R.J. Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochim Biophys Acta 2009, 1792:506-520.
12. Gil J.M., Rego A.C. Mechanisms of neurodegeneration in Huntington's disease. Eur J Neurosci 2008, 27:2803-2820.
13. Grove M., Vonsattel J.P., Mazzoni P., Marder K. Huntington's disease. Sci Aging Knowledge Environ 2003, 43:1-14.
14. Gu X., André V.M., Cepeda C., Li S.H., Li X.J., Levine M.S., et al. Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease. Mol Neurodegener 2007, 2:8.
15. Gunčová I., Mazurová Y., Rudolf E., Látr I. The up-regulation of nestin, vimentin and GFAP intermediate filaments in reactive astrocytes in response to neurodegenerative process within the striatum. Acta Histochem 2009, 111:434-435. (Abstract).
16. Gusella J.F., MacDonald M.E., Ambrose C.M., Duyao M.P. Molecular genetics of Huntington's disease. Arch Neurol 1993, 50:1157-1163.
17. Hampton D.W., Rhodes K.E., Zhao C., Franklin R.J., Fawcett J.W. The responses of oligodendrocyte precursor cells, astrocytes and microglia to a cortical stab injury, in the brain. Neuroscience 2004, 127:813-820.
18. Kántor O., Temel Y., Holzmann C., Raber K., Nguyen H.P., Cao C., et al. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats. Neurobiol Dis 2006, 22:538-547.
19. Kimelberg H.K. The problem of astrocyte identity. Neurochem Int 2004, 45:191-202.
20. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
21. Maragakis N.J., Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2006, 2:679-689.
22. Mathiisen T.M., Lehre K.P., Danbolt N.C., Ottersen O.P. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 2010, 58:1094-1103.
23. Mazurová Y., Látr I., Österreicher J., Gunčová I. Progressive reparative gliosis in aged hosts and interferences with neural grafts in an animal model of Huntington's disease. Cell Mol Neurobiol 2006, 26:1423-1441.
24. Menalled L.B., Chesselet M.F. Mouse models of Huntington's disease. Trends Pharmacol Sci 2002, 23:32-39.
25. Myers R.H., Vonsattel J.P., Paskevich P.A., Kiely D.K., Stevens T.J., Cupples L.A., et al. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 1991, 50:729-742.
26. Nedergaard M., Ransom B., Goldman S.A. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 2003, 26:523-530.
27. Nishiyama A. Polydendrocytes: NG2 cells with many roles in development and repair of the CNS. Neuroscientist 2007, 13:62-76.
28. Pekny M., Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 2004, 204:428-437.
29. Ramaswamy S., McBride J.L., Kordower J.H. Animal models of Huntington's disease. ILAR J 2007, 48:356-373.
30. Ross C.A., Margolis R.L. Huntington's disease. Clin Neurosci Res 2001, 1:142-152.
31. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol 2010, 119:7-35.
32. Takamiya Y., Kohsaka S., Toya S., Otani M., Tsukada Y. Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats. Brain Res 1988, 466:201-210.
33. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
34. von Hörsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., et al. Transgenic rat model of Huntington's disease. Hum Mol Genet 2003, 12:617-624.
35. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985, 44:559-577.
36. Vonsattel J.P. Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 2008, 115:55-69.
37. Wang L.H., Qin Z.H. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies. Acta Pharmacol Sin 2006, 27:1287-1302.
38. Wigley R., Butt A.M. Integration of NG2-glia (synantocytes) into the neuroglial network. Neuron Glia Biol 2009, 5:21-28.